Long-term goals are more important than short-term solutions at Lundbeck. After speaking with the CEO, Danish financial daily Børsen reports that if the company wants to grow, a larger acquisition would be a clear option, but in Lundbeck's case, risk is a big concern for the foundation that owns the firm.
"I think that the Lundbeck Foundation would support an acquisition like this if we presented an attractive case that is really a quantum leap for Lundbeck, but we also need to demonstrate that if things don't all go to plan, and the wind is against us, it won't derail the company," says CEO Deborah Dunsire.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Client Talent Acquisition Specialist 
Key Account Manager, Europe and Asia 
Biostatistician 
Senior Project Manager (GMP - Life Science) 
Chemist for Incoming Materials in QC Department 
Account Manager 
Project Manager & Scrum Master 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Director Global Engineering 
2 Sales Representatives and Product Specialists 
Innovation Project Manager, Display Unit 
Clinical Trial Manager 
Senior Chemical Safety Advisor 
System Sales Development Consultant - Investment Projects, Merck Millipore 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Director for innovative pre-clinical testing unit 
Biomarker Operations Lead